Document Classification

Section Type: RESULTS

Text: The changes in HbA1c (-0. 74 and -0. 76 vs + 0. 29 %), fasting plasma glucose (1 mg/dl = 0. 0555 mmol/l ; -31. 6 and -31. 9 vs + 3. 7 mg/dl), 2-h plasma glucose after 75-g glucose load (-84. 9 and -79. 0 vs -0. 5 mg/dl), body weight (percent change : -3. 76 and -4. 02 vs -0. 76 %) and systolic blood pressure (-7. 88 and -6. 24 vs -2. 72 mmHg) were significantly greater with 100 and 200 mg canagliflozin than with placebo (all, p < 0. 05).